Where has NP made its mark over the last century
Historically successful in the anti-infective and cyto-toxicity markets
Reasonable success in pharmacological screening (neurological, immunological)
Jury still out on mechanism based screens
Previous slide
Next slide
Back to first slide
View graphic version